VI Therapeutics
Agent34Agent Readiness: 34/100. Below median. Measured by StartupHub.ai. Median 41.Trust85Data Trust: 85/100. Top 25%. Measured by StartupHub.ai. Median 61.VI Therapeutics is developing novel therapies for rare genetic diseases.
About this profileCompany details: from public sourcesFunding: no announced round on fileOwnership: not yet claimed by the companyScores: measured by named tools; each links to its methodOur rules
About
VI Therapeutics is a biotechnology company focused on developing gene therapies for rare genetic diseases. They leverage their proprietary gene editing and delivery technologies to create transformative treatments for patients with unmet medical needs.
Listed competitors
A clinical-stage biotechnology company developing transformative genome editing medicines for serious diseases.
Biotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.
A clinical-stage genome editing company developing novel therapies using CRISPR/Cas9 technology for severe diseases.
Also in this space
AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.
Shares Life Sciences, Biotech
Computational platform using LLMs trained on biological and chemical data for drug discovery.
Shares Life Sciences, Drug Discovery
AI-driven platform for protein-level disease mapping and drug discovery.
Shares Life Sciences, Drug Discovery
AI-powered blood test for early cancer detection and subtyping.
Shares Life Sciences, Biotech
Compressing biology to develop the next generation of therapies.
Shares Life Sciences, Drug Discovery
AI-powered insights platform for life sciences and biotech workflows.
Shares Life Sciences, Biotech
Key facts
- Website
- vi-therapeutics.com
- Headquarters
- Cambridge, United States
- Founded
- 2017
- Business model
- B2B
VI Therapeutics scores 34. Does yours?
That is its Agent Readiness: how well ChatGPT, Claude and the other agents can read and use a site. Paste your website and you get yours in about a minute.
Frequently asked
Is VI Therapeutics trustworthy and reputable?
StartupHub's Data Trust & Reputation score for VI Therapeutics is 85 out of 100, a trusted rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
Public record
SEC filings, insider activity, nonprofit links and pay benchmarks for VI Therapeutics
